Fda says granted approval to givlaari for treatment of acute hepatic porphyria

Fda says granted approval to givlaari (givosiran) for treatment of adult patients with acute hepatic porphyria.fda says granted approval of givlaari to alnylam pharmaceuticals.

ALNY Ratings Summary

ALNY Quant Ranking